Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
BABA-W
09988
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 75.25%105.67K | 51.46%-277.65K | -5.19%-2.13M | -17.18%-611.68K | -394.34%-1.01M | 110.66%60.3K | 22.00%-571.99K | -171.70%-2.02M | -40.34%-522.02K | 80.25%-203.54K |
| Net income from continuing operations | 39.99%-426.51K | 42.99%-437.86K | -111.10%-6.75M | -435.85%-4.69M | 18.92%-573.82K | 0.93%-710.71K | 14.15%-768.05K | 53.91%-3.2M | 87.63%-875.84K | -43.57%-707.69K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --199.52K | ---- | ---- |
| Depreciation and amortization | --0 | --0 | -70.90%311.3K | --0 | -87.32%34.82K | -39.39%135K | -64.83%117.74K | -73.45%1.07M | -90.07%237.44K | 74.55%274.74K |
| Asset impairment expenditure | ---- | ---- | --2.94M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | --0 | --0 | 81.98%335.36K | 283.43%141.49K | --0 | --0 | 167.30%193.87K | -60.08%184.28K | -60.62%36.9K | -61.37%37.43K |
| Other non cashItems | 116.86%15.6K | 45.89%14.46K | 1,212.35%1.25M | 1,803.54%1.21M | 79.33%21.04K | -32.69%7.2K | 9.25%9.91K | 168.68%94.94K | 568.07%63.45K | 31.53%11.73K |
| Change In working capital | -17.85%516.58K | 216.18%145.76K | 42.66%-216.37K | -13.24%-207.78K | -370.84%-488.21K | 627.97%628.81K | 50.80%-125.46K | -137.73%-377.33K | -970.12%-183.48K | 122.51%180.26K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 75.25%105.67K | 51.46%-277.65K | -5.19%-2.13M | -17.18%-611.68K | -394.34%-1.01M | 110.66%60.3K | 22.00%-571.99K | -171.70%-2.02M | -40.34%-522.02K | 80.25%-203.54K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,249.27%-953.64K | -559.53%-641.11K | -465.70%-1.43M | -452.36%-1.19M | -135.53%-70.32K | 48.53%-70.68K | 85.06%-97.21K | 97.92%-252.47K | 116.27%337.73K | 117.78%197.93K |
| Capital expenditure reported | --0 | --0 | 88.52%-33.79K | 157.99%78.62K | -3.36%-52.77K | 3.75%-39.75K | 69.99%-19.9K | 93.08%-294.23K | -210.28%-135.58K | 94.78%-51.05K |
| Net PPE purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | 0.00%-23.74K | --215.25K | ---- | ---- |
| Net investment purchase and sale | 32.74%-3.83K | -47.90%-37.51K | 39.41%-40.08K | -37.56%-7.3K | 96.36%-1.73K | -17.16%-5.69K | -195.31%-25.36K | 40.66%-66.15K | -105.38%-5.3K | 41.55%-47.4K |
| Net other investing changes | -3,663.86%-949.81K | -2,039.23%-603.6K | -1,161.66%-1.35M | -577.80%-1.26M | -106.35%-18.82K | 72.32%-25.24K | 94.89%-28.22K | 98.62%-107.35K | 111.99%263.36K | 652.77%296.38K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,249.27%-953.64K | -559.53%-641.11K | -465.70%-1.43M | -451.47%-1.19M | -137.04%-73.32K | 48.53%-70.68K | 85.06%-97.21K | 97.92%-252.47K | 116.27%337.73K | 117.78%197.93K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 840K | -85.12%100K | 86.57%4.23M | -132.65%-63.3K | 3,900.13%3.63M | 0 | -49.64%672.24K | -42.71%2.27M | -79.33%193.86K | -93.55%90.63K |
| Net issuance payments of debt | ---- | ---- | 33.33%-63.3K | ---- | ---- | ---- | ---- | -171.87%-94.94K | ---- | ---- |
| Net common stock issuance | --0 | --0 | 87.40%4.53M | -106.40%-21.9K | 3,940.58%3.66M | --0 | --890.85K | -1.00%2.42M | --342.17K | --90.63K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other financing activities | --840K | 145.74%100K | -337.25%-233.37K | --21.9K | ---36.66K | ---- | -116.38%-218.61K | 36.63%-53.37K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --840K | -85.12%100K | 86.57%4.23M | -132.65%-63.3K | 3,900.13%3.63M | --0 | -49.64%672.24K | -42.71%2.27M | -79.33%193.86K | -93.55%90.63K |
| Net cash flow | ||||||||||
| Beginning cash position | -90.40%15.44K | 428.69%834.2K | -4.53%157.79K | 1,719.04%2.7M | 138.07%150.45K | 38.51%160.83K | -4.53%157.79K | -97.01%165.27K | -91.15%148.22K | -97.38%63.2K |
| Current changes in cash | 23.24%-7.97K | -26,970.96%-818.76K | 9,134.49%676.41K | -19,564.73%-1.86M | 2,894.15%2.55M | 80.38%-10.38K | 106.20%3.05K | 99.86%-7.49K | 100.63%9.57K | 111.51%85.02K |
| End cash Position | -95.03%7.47K | -90.40%15.44K | 428.69%834.2K | 428.69%834.2K | 1,719.04%2.7M | 138.07%150.45K | 38.51%160.83K | -4.53%157.79K | -4.53%157.79K | -91.15%148.22K |
| Free cash from | 414.29%105.67K | 54.90%-277.65K | 6.70%-2.16M | 18.94%-533.06K | -315.94%-1.06M | 103.39%20.55K | 25.23%-615.62K | -62.08%-2.32M | -164.09%-657.6K | 87.33%-254.59K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.